SANGAMO THERAPEUTICS, INC. Retained Earnings
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Retained Earnings of -$1.66 billion as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-14
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.66B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.63B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.59B.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$1.55B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-03-31 | -$1.66B 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$1.63B 10-Q · filed 2026-05-14 |
| 2025-09-30 | -$1.59B 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$1.55B 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$1.53B 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$1.50B 10-K · filed 2026-03-30 |
| 2024-09-30 | -$1.48B 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$1.49B 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$1.46B 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$1.41B 10-K · filed 2025-03-17 |
| 2023-09-30 | -$1.35B 10-Q · filed 2023-11-01 |
| 2023-06-30 | -$1.24B 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$1.13B 10-Q · filed 2023-05-08 |
| 2022-12-31 | -$1.15B 10-K · filed 2024-03-13 |
| 2022-09-30 | -$1.10B 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$1.04B 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$1.00B 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$956.27M 10-K · filed 2023-02-23 |
| 2021-09-30 | -$918.77M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$871.08M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$823.91M 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$777.98M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$737.38M 10-Q · filed 2020-11-04 |
| 2020-06-30 | -$735.83M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$699.90M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$656.99M 10-K · filed 2021-02-24 |
| 2019-09-30 | -$661.54M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$634.23M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$603.95M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$562.70M 10-K · filed 2020-02-28 |
| 2018-09-30 | -$544.03M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$531.19M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$514.55M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$495.48M 10-K · filed 2019-03-01 |
| 2017-09-30 | -$482.39M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$470.03M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$457.54M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$440.91M 10-K · filed 2018-03-01 |
| 2016-09-30 | -$431.29M 10-Q · filed 2016-10-27 |
| 2016-06-30 | -$412.32M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$385.75M 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$369.25M 10-K · filed 2017-02-28 |
| 2015-09-30 | -$355.24M 10-Q · filed 2015-10-30 |
| 2015-06-30 | -$346.00M 10-Q · filed 2015-08-06 |
| 2015-03-31 | -$333.87M 10-Q · filed 2015-04-28 |
| 2014-12-31 | -$328.55M 10-K · filed 2016-02-18 |
| 2014-09-30 | -$324.23M 10-Q · filed 2014-10-28 |
| 2014-06-30 | -$316.69M 10-Q · filed 2014-07-29 |
| 2014-03-31 | -$309.70M 10-Q · filed 2014-05-07 |
| 2013-12-31 | -$302.13M 10-K · filed 2015-02-25 |
| 2013-09-30 | -$293.99M 10-Q · filed 2013-11-04 |
| 2013-06-30 | -$287.84M 10-Q · filed 2013-08-02 |
| 2013-03-31 | -$282.39M 10-Q · filed 2013-05-09 |
| 2012-12-31 | -$275.51M 10-K · filed 2014-02-24 |
| 2012-09-30 | -$272.03M 10-Q · filed 2012-11-02 |
| 2012-06-30 | -$266.24M 10-Q · filed 2012-08-03 |
| 2012-03-31 | -$260.51M 10-Q · filed 2012-05-07 |
| 2011-12-31 | -$253.25M 10-K · filed 2013-02-26 |
| 2011-09-30 | -$246.89M 10-Q · filed 2011-11-04 |
| 2011-06-30 | -$237.33M 10-Q · filed 2011-08-05 |
| 2010-12-31 | -$217.50M 10-K · filed 2012-02-23 |